Updates and perspectives from our industry experts, scientists and product leaders.
Uncover the emerging role of AI in gene therapy and how it is paving the way for groundbreaking advancements.
Discover how Form Bio and Google Cloud’s Multiomics Suite will empower life scientists to accelerate research, development, and pre-clinical studies in personalized medicine and gene therapies.
Learn how predictive modeling can generate synthetic regulatory sequences for safer and more efficacious gene therapies.
We support the commitment of the Biden-Harris Administration to address global issues through biomanufacturing innovation. Learn more.
Recent published research is bringing us one step closer to predicting molecular phenotypes from a DNA sequence. Read this blog to learn more.
Joe Nipko, PhD
December 6, 2023
2023-12-06
Chris Haas
June 13, 2023
2023-06-13
Nick Ketz, PhD
May 3, 2023
2023-05-03
Andrew Busey & Kent Wakeford
March 27, 2023
2023-03-27
Austin Day, PhD
February 10, 2023
2023-02-10
Jill Roughan, PhD
August 6, 2024
2024-08-06
Explore the AAV production process for gene therapy manufacturing, as well as the techniques and efficiency improvements to enhance AAV payload purity.
Claire Aldridge, PhD
July 9, 2024
2024-07-09
Discover why AAV vectors are key to gene therapy success, offering precise delivery, wide clinical applications, and transformative impact in genetic disease treatment.
Bijan Zakeri, PhD
June 4, 2024
2024-06-04
Discover how AI-assisted biological lab experiments accelerate AAV research and de-risk vector design.
May 21, 2024
2024-05-21
See how AAV product characterization can be optimized using next-generation sequencing (NGS).
May 7, 2024
2024-05-07
Discover five simple steps to analyze DNA sequence data and uncover valuable insights effortlessly with point and click Form Bio workflows.
Anusha Sriraman, PhD
April 23, 2024
2024-04-23
Explore Form Bio's AI models that predict, optimize, and de-risk AAV vector design outcomes.
Angela Anderson
April 18, 2024
2024-04-18
Meet the members of Form Bio’s new Scientific Advisory Board, helping to guide our groundbreaking cell and gene therapy innovation.